This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Frecer, V. Articles by Ding, J. L. Search for Related Content PubMed PubMed Citation Articles by Frecer, V. Articles by Ding, J. L.

De Novo Design of Potent Antimicrobial Peptides

Department of Biological Sciences, Faculty of Science,¹ Department of Microbiology, Faculty of Medicine, National University of Singapore, Singapore, Republic of Singapore²

Received 17 November 2003/ Returned for modification 2 February 2004/ Accepted 1 May 2004

Lipopolysaccharide (LPS), shed by gram-negative bacteria during infection and antimicrobial therapy, may lead to lethal endotoxic shock syndrome. A rational design strategy based on the presumed mechanism of antibacterial effect was adopted to design cationic antimicrobial peptides capable of binding to LPS through tandemly repeated sequences of alternating cationic and nonpolar residues. The peptides were designed to achieve enhanced antimicrobial potency due to initial bacterial membrane binding with a reduced risk of endotoxic shock. The peptides designed displayed binding affinities to LPS and lipid A (LA) in the low micromolar range and by molecular modeling were predicted to form amphipathic ß-hairpin-like structures when they bind to LPS or LA. They also exhibited strong effects against gram-negative bacteria, with MICs in the nanomolar range, and low cytotoxic and hemolytic activities at concentrations significantly exceeding their MICs. Quantitative structure-activity relationship (QSAR) analysis of peptide sequences and their antimicrobial, cytotoxic, and hemolytic activities revealed that site-directed substitutions of residues in the hydrophobic face of the amphipathic peptides with less lipophilic residues selectively decrease the hemolytic effect without significantly affecting the antimicrobial or cytotoxic activity. On the other hand, the antimicrobial effect can be enhanced by substitutions in the polar face with more polar residues, which increase the amphipathicity of the peptide. On the basis of the QSARs, new analogs that have strong antimicrobial effects but that lack hemolytic activity can be proposed. The findings highlight the importance of peptide amphipathicity and allow a rational method that can be used to dissociate the antimicrobial and hemolytic effects of cationic peptides, which have potent antimicrobial properties, to be proposed.

This article has been cited by other articles:

• Jang, W. S., Lee, S.-C., Lee, Y. S., Shin, Y. P., Shin, K. H., Sung, B. H., Kim, B. S., Lee, S. H., Lee, I. H. (2007). Antimicrobial Effect of Halocidin-Derived Peptide in a Mouse Model of Listeria Infection. Antimicrob. Agents Chemother. 51: 4148-4156 [Abstract] [Full Text]  
• Radzishevsky, I., Krugliak, M., Ginsburg, H., Mor, A. (2007). Antiplasmodial Activity of Lauryl-Lysine Oligomers. Antimicrob. Agents Chemother. 51: 1753-1759 [Abstract] [Full Text]